4
Changes in Ownership
Enveric Biosciences, Inc. Filed Acc 0000921895-16-004598
Director acquired 1,111,111 shares (option exercise)
- Director acquired 60 shares (code L)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eberwein Jeffrey E. Director | 2016-05-13 | Option exercise | +1,111,111 | $1.80 | $2,000,000 | 1,666,755 | I |
| Eberwein Jeffrey E. Director | 2016-05-09 | Other acquisition | +3 | $6.51 | $20 | 40,621 | I |
| Eberwein Jeffrey E. Director | 2016-05-13 | Other acquisition | +12 | $6.51 | $78 | 40,633 | I |
| Eberwein Jeffrey E. Director | 2016-05-17 | Other acquisition | +45 | $6.51 | $293 | 40,678 | I |
| Derivatives | |||||||
| Eberwein Jeffrey E. Director | 2016-05-13 | Option exercise · Warrant (Right to Buy) | −1,111,111 | 1,666,666 | I | ||
| Eberwein Jeffrey E. Director | 2016-05-13 | Other acquisition · Warrant (Right to Buy) | +1,000,000 | 1,000,000 | I | ||
| Eberwein Jeffrey E. Director | 2016-05-13 | Other acquisition · 5% Convertible Note due May 2017 | +0 | $5,000,000.00 | $0 | I | |
Loading xslF345X03/form410211002_05172016.xml…